Tilray ( (TLRY) ) has released its Q4 earnings. Here is a breakdown of the information Tilray presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tilray Brands, Inc. is a global lifestyle consumer packaged goods company operating in the cannabis, beverage, and wellness industries, with a significant presence in Canada, the United States, Europe, Australia, and Latin America. The company is known for its diverse portfolio of over 40 brands and innovative products aimed at enhancing consumer experiences.
In its latest earnings report for the fiscal year 2025, Tilray Brands reported net revenue of $821 million, marking a 4% increase from the previous year. The company highlighted significant growth in its international cannabis revenue, which increased by 19% for the fiscal year and 71% in the fourth quarter. Additionally, Tilray’s beverage and wellness segments saw revenue growth of 19% and 9%, respectively.
Key financial performance metrics revealed that Tilray’s global cannabis gross margin improved by 700 basis points, while the company maintained its leading position in Canadian cannabis revenue. Despite a decline in cannabis and beverage net revenue in the fourth quarter compared to the previous year, Tilray achieved a strong balance sheet with $256 million in cash and marketable securities and reduced its total debt by approximately $100 million.
Tilray’s strategic initiatives included the acquisition of four craft beer brands from Molson Coors, the introduction of hemp-derived Delta-9 THC drinks in the U.S., and leveraging AI technology to optimize operations. Looking ahead, the company anticipates substantial growth opportunities in emerging markets across Europe, the Middle East, India, Türkiye, and Asia, with a focus on non-alcoholic beverages and hemp-based food products.
Tilray’s management remains optimistic about fiscal year 2026, projecting adjusted EBITDA between $62 million and $72 million, reflecting growth of 13% to 31% compared to fiscal year 2025. The company aims to capitalize on its global infrastructure and distribution network to lead in the expanding global cannabis market, driven by innovation and strategic growth initiatives.